
26/02/2024
PCM TRIALS - Quality Mobile Research + EmVenio Research become the largest independent DCT Site Network and Global Mobile Visit provider. The two companies are coming together to break down barriers and make clinical research more accessible to all patients, especially those with diverse backgrounds and ethnicities. By combining PCM Trials’ market leadership in mobile visits and EmVenio’s community-based mobile site network, we are committed to reducing research participation challenges and improving participants’ overall experience.
We are thrilled to offer patient-centric clinical research on a local level, globally!
Read the full release here 👉 https://hubs.ly/Q02m50vn0